FDA Inspection
Ascension Saint John Medical CenterAscension Saint John Medical Center – FDA Inspection, May 9, 2025
Record Details
This FDA Inspection record concerns Ascension Saint John Medical Center, with an inspection on May 9, 2025, issued by the Dallas District Office, covering biologics.
View Company Profile
ID · 82cb7ef6-f98e-4d16-8587-a160b502896c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1269887
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.100(c)Record review prior to release
- 21 CFR 606.100(c)Thorough investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ascension Saint John Medical Center
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 19, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 1, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 11, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 4, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 14, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Ascension Saint John Medical Center
- FDA Inspection 1178182 - 2022-07-19
- FDA Inspection 1034393 - 2017-12-01
- FDA Inspection 964421 - 2016-03-11
- FDA Inspection 868330 - 2014-03-04
- FDA Inspection 767466 - 2012-02-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.